Organogenesis Holdings, Inc. Class A
(NASDAQ : ORGO)

( )
ORGO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
JPMJPMorgan Chase & Co.
-0.35%106.820.9%$1284.47m
CCitigroup Inc.
-0.44%65.640.8%$962.02m
AXPAmerican Express Company
-0.76%112.691.6%$356.41m
PRUPrudential Financial, Inc.
-0.46%96.801.3%$205.30m
PFGPrincipal Financial Group, Inc.
-1.63%51.931.9%$105.11m
INGING Groep NV Sponsored ADR
-0.32%12.420.2%$43.39m
LYGLloyds Banking Group plc Sponsored ADR
-0.29%3.420.1%$19.41m
SLFSun Life Financial Inc.
0.89%38.990.2%$19.16m
SHGShinhan Financial Group Co., Ltd. Sponsored ADR
-1.49%38.370.1%$3.59m
MFGMizuho Financial Group, Inc. Sponsored ADR
0.16%3.100.0%$1.41m
AVALGrupo Aval Acciones y Valores Grupo Sponsored ADR Pfd
0.90%7.870.1%$1.08m
WFWoori Bank Sponsored ADR
-0.30%39.510.0%$0.96m
KINSKingstone Companies, Inc.
0.60%15.090.2%$0.49m
FBIZFirst Business Financial Services, Inc.
-1.23%20.880.8%$0.22m

Company Profile

Organogenesis Holdings, Inc. designs and manufactures regenerative medical products. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in October 2016 and is headquartered in Canton, MA.